MEDIAN TECHNOLOGIES (ALMDT.PA) Stock Fundamental Analysis

Europe • Euronext Paris • EPA:ALMDT • FR0011049824

4.28 EUR
-0.01 (-0.35%)
Last: Feb 6, 2026, 07:00 PM
Fundamental Rating

2

ALMDT gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 11 industry peers in the Health Care Technology industry. ALMDT has a bad profitability rating. Also its financial health evaluation is rather negative. ALMDT is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year ALMDT has reported negative net income.
  • ALMDT had a negative operating cash flow in the past year.
  • In the past 5 years ALMDT always reported negative net income.
  • ALMDT had a negative operating cash flow in each of the past 5 years.
ALMDT.PA Yearly Net Income VS EBIT VS OCF VS FCFALMDT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M -25M

1.2 Ratios

  • The Return On Assets of ALMDT (-113.84%) is worse than 83.33% of its industry peers.
Industry RankSector Rank
ROA -113.84%
ROE N/A
ROIC N/A
ROA(3y)-75.23%
ROA(5y)-63.07%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALMDT.PA Yearly ROA, ROE, ROICALMDT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600

1.3 Margins

  • ALMDT has a better Gross Margin (102.73%) than 100.00% of its industry peers.
  • ALMDT's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for ALMDT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 102.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.46%
GM growth 5Y0.99%
ALMDT.PA Yearly Profit, Operating, Gross MarginsALMDT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

0

2. Health

2.1 Basic Checks

  • ALMDT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for ALMDT has been increased compared to 1 year ago.
  • ALMDT has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for ALMDT is higher compared to a year ago.
ALMDT.PA Yearly Shares OutstandingALMDT.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ALMDT.PA Yearly Total Debt VS Total AssetsALMDT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

  • Based on the Altman-Z score of -12.15, we must say that ALMDT is in the distress zone and has some risk of bankruptcy.
  • ALMDT has a Altman-Z score of -12.15. This is in the lower half of the industry: ALMDT underperforms 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -12.15
ROIC/WACCN/A
WACC7.62%
ALMDT.PA Yearly LT Debt VS Equity VS FCFALMDT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

  • A Current Ratio of 0.35 indicates that ALMDT may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.35, ALMDT is doing worse than 83.33% of the companies in the same industry.
  • ALMDT has a Quick Ratio of 0.35. This is a bad value and indicates that ALMDT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ALMDT has a worse Quick ratio (0.35) than 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 0.35
Quick Ratio 0.35
ALMDT.PA Yearly Current Assets VS Current LiabilitesALMDT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

6

3. Growth

3.1 Past

  • ALMDT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.99%, which is quite good.
  • ALMDT shows a small growth in Revenue. In the last year, the Revenue has grown by 6.75%.
  • ALMDT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 20.72% yearly.
EPS 1Y (TTM)9.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30%
Revenue 1Y (TTM)6.75%
Revenue growth 3Y3.75%
Revenue growth 5Y20.72%
Sales Q2Q%3.3%

3.2 Future

  • ALMDT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.15% yearly.
  • ALMDT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 22.71% yearly.
EPS Next Y33.59%
EPS Next 2Y30.92%
EPS Next 3Y26.15%
EPS Next 5YN/A
Revenue Next Year3.31%
Revenue Next 2Y17.55%
Revenue Next 3Y22.71%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ALMDT.PA Yearly Revenue VS EstimatesALMDT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M
ALMDT.PA Yearly EPS VS EstimatesALMDT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.5 -1

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ALMDT. In the last year negative earnings were reported.
  • Also next year ALMDT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALMDT.PA Price Earnings VS Forward Price EarningsALMDT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALMDT.PA Per share dataALMDT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ALMDT's earnings are expected to grow with 26.15% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.92%
EPS Next 3Y26.15%

0

5. Dividend

5.1 Amount

  • No dividends for ALMDT!.
Industry RankSector Rank
Dividend Yield 0%

MEDIAN TECHNOLOGIES

EPA:ALMDT (2/6/2026, 7:00:00 PM)

4.28

-0.01 (-0.35%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)10-23
Earnings (Next)04-27
Inst Owners10.84%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap157.16M
Revenue(TTM)23.31M
Net Income(TTM)-22.21M
Analysts85.45
Price Target8.81 (105.84%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-24.4%
EPS NY rev (3m)-122.22%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.74
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.16
EYN/A
EPS(NY)-0.38
Fwd EYN/A
FCF(TTM)-0.4
FCFYN/A
OCF(TTM)-0.38
OCFYN/A
SpS0.63
BVpS-1.1
TBVpS-1.15
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -113.84%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 102.73%
FCFM N/A
ROA(3y)-75.23%
ROA(5y)-63.07%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.46%
GM growth 5Y0.99%
F-Score2
Asset Turnover1.19
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 36.46%
Cap/Sales 3.39%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.35
Quick Ratio 0.35
Altman-Z -12.15
F-Score2
WACC7.62%
ROIC/WACCN/A
Cap/Depr(3y)102.16%
Cap/Depr(5y)84.24%
Cap/Sales(3y)5.46%
Cap/Sales(5y)4.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30%
EPS Next Y33.59%
EPS Next 2Y30.92%
EPS Next 3Y26.15%
EPS Next 5YN/A
Revenue 1Y (TTM)6.75%
Revenue growth 3Y3.75%
Revenue growth 5Y20.72%
Sales Q2Q%3.3%
Revenue Next Year3.31%
Revenue Next 2Y17.55%
Revenue Next 3Y22.71%
Revenue Next 5YN/A
EBIT growth 1Y26.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year25.89%
EBIT Next 3Y24.38%
EBIT Next 5YN/A
FCF growth 1Y23.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y21.85%
OCF growth 3YN/A
OCF growth 5YN/A

MEDIAN TECHNOLOGIES / ALMDT.PA FAQ

What is the ChartMill fundamental rating of MEDIAN TECHNOLOGIES (ALMDT.PA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to ALMDT.PA.


What is the valuation status for ALMDT stock?

ChartMill assigns a valuation rating of 1 / 10 to MEDIAN TECHNOLOGIES (ALMDT.PA). This can be considered as Overvalued.


What is the profitability of ALMDT stock?

MEDIAN TECHNOLOGIES (ALMDT.PA) has a profitability rating of 1 / 10.


How financially healthy is MEDIAN TECHNOLOGIES?

The financial health rating of MEDIAN TECHNOLOGIES (ALMDT.PA) is 0 / 10.